{Reference Type}: Journal Article
{Title}: Impact of the creation of specialized units for patients with hypertrophic cardiomyopathy.
{Author}: Negreira-Caamaño M;Piqueras-Flores J;Vivo-Ortega I;Arántzazu-González-Marín M;Muñoz-García M;Jiménez-Lozano A;
{Journal}: Rev Port Cardiol (Engl Ed)
{Volume}: 40
{Issue}: 3
{Year}: Mar 2021
暂无{DOI}: 10.1016/j.repc.2020.08.012
{Abstract}: <B>OBJECTIVE: </B>According to current international guidelines, hypertrophic cardiomyopathy (HCM) patients should be managed in specialized units. However, there is lack of data on the impact of the creation of these units in the management of HCM patients. Our goal was to assess the impact of the creation of an Inherited Inherited Diseases Cardiac Unit (ICDU) in the current management of patients with HCM.<BR><B>METHODS: </B>We analyzed 114 consecutive patients (62.6±8 years old, 70.2% males) with HCM. Variables related to optimal management of HCM patients and their family study were recorded, as well as guidance on the risk of sudden death. We analyzed whether patients were assessed by the ICDU or at a general cardiology consultation (GCC).<BR><B>RESULTS: </B>50 patients were assessed in the IDCU and 64 in the GCC. Familial screening was more frequent in patients assessed by the IDCU (45.3% vs. 4%; p<0.01), requesting more genetic studies of the index case (70.3% vs. 14%; p<0.01) and cardiac magnetic resonance (53.1% vs. 18%; p<0.01). Sudden death risk score was performed more frequently in patients after the creation of an IDCU (67.2% vs. 28%; p<0.01). Treatment with beta-blockers was similar in both groups (72% vs. 78.1%; p=0.24). An implantable cardiac defibrillator was indicated similarly in both groups (12.5% in ICDU and 6% in GC; p=0.24).<BR><B>CONCLUSIONS: </B>The implementation of an IDCU improved the quality of the medical care for HCM patients by performing a better study of the patients and their families.